Ray Zemlin, a senior partner in Goodwin’s Technology Companies and Life Sciences Groups, focuses primarily on securities law, mergers and acquisitions, and corporate finance matters for medical device and other companies. He has more than 30 years’ experience representing issuers and underwriters in public and private offerings of equity and debt securities, as well as counseling numerous public companies on securities law, governance and other issues. In addition, he has represented purchasers or sellers in hundreds of merger and acquisition transactions, including representing ZOLL Medical in its $2.2 billion sale to Asahi Kasei, and advised managements and boards of directors on a host of corporate governance and related matters.
Mr. Zemlin is a recognized leader in the medical device community and has served on the board of directors of MassMEDIC, the country’s largest medical device industry council.
Mr. Zemlin represents clients primarily in the technology and service industries, with a particular focus in the life sciences and medical device industry. His recent representations include:
Mr. Zemlin has served on the board of directors of MassMEDIC, the country's largest medical device industry council. He is also a member of the Business Law Section of the American Bar Association and the Boston Bar Association.
Mr. Zemlin served as articles editor for the Cornell Law Review at Cornell Law School.
Mr. Zemlin has lectured at many seminars concerning securities law and other matters impacting the medical device industry.
(Order of the Coif)
(summa cum laude)
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。